{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:38:33Z","timestamp":1792737513489,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jacbts.2021.11.004","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T15:37:30Z","timestamp":1646840250000},"page":"608-625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Cardiovascular Disease in Duchenne\u00a0Muscular Dystrophy"],"prefix":"10.1016","volume":"7","author":[{"given":"Taylor I.","family":"Schultz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Frank J.","family":"Raucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi N.","family":"Salloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2021.11.004_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.2014-2044","article-title":"Prevalence of Duchenne and Becker muscular dystrophies in the United States","volume":"135","author":"Romitti","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.jacbts.2021.11.004_bib2","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.045559","article-title":"Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy","volume":"13","author":"Gartz","year":"2020","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jacbts.2021.11.004_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jsmc.2020.08.011","article-title":"Lifetime care of Duchenne muscular dystrophy","volume":"15","author":"MacKintosh","year":"2020","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.jacbts.2021.11.004_bib4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF00442472","article-title":"Short stature: a common feature in Duchenne muscular dystrophy","volume":"147","author":"Eiholzer","year":"1988","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.1016\/j.jacbts.2021.11.004_bib5","article-title":"Predictors of death in adults with Duchenne muscular dystrophy-associated cardiomyopathy","volume":"6","author":"Cheeran","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.11.004_bib6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ejpn.2016.07.020","article-title":"Why are some patients with Duchenne muscular dystrophy dying young: an analysis of causes of death in North East England","volume":"20","author":"Van Ruiten","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.57.6.1122","article-title":"An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy","volume":"57","author":"Sanyal","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.11.004_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.0b013e318221ad14","article-title":"Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy","volume":"77","author":"Schade van Westrum","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jacbts.2021.11.004_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ehjci\/jev161","article-title":"Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study","volume":"17","author":"Florian","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacbts.2021.11.004_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2017.12.024","article-title":"Detection and management of cardiomyopathy in female dystrophinopathy carriers","volume":"386","author":"Adachi","year":"2018","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jacbts.2021.11.004_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e318227b164","article-title":"Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy","volume":"77","author":"Escolar","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jacbts.2021.11.004_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nm0502-473","article-title":"Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase","volume":"8","author":"Hafezi-Moghadam","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2021.11.004_bib13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00246-005-0909-4","article-title":"Steroid therapy and cardiac function in Duchenne muscular dystrophy","volume":"26","author":"Markham","year":"2005","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0002-9149(02)03429-X","article-title":"Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy","volume":"91","author":"Silversides","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/1060028019900500","article-title":"A\u00a0review of deflazacort for patients with Duchenne muscular dystrophy","volume":"54","author":"Bylo","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacbts.2021.11.004_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A\u00a0practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"24","key":"10.1016\/j.jacbts.2021.11.004_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132402","article-title":"Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming","volume":"4","author":"Quattrocelli","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2021.11.004_bib18","first-page":"913","article-title":"Management of airway clearance in neuromuscular disease","volume":"51","author":"Boitano","year":"2006","journal-title":"RespirCare"},{"key":"10.1016\/j.jacbts.2021.11.004_bib19","first-page":"Cd001941","article-title":"Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders","volume":"2014","author":"Annane","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacbts.2021.11.004_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011381","article-title":"Natural history of cardiac function in Duchenne and Becker muscular dystrophies on home mechanical ventilation","volume":"97","author":"Fayssoil","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.jacbts.2021.11.004_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2013.05.003","article-title":"Scoliosis in Duchenne muscular dystrophy (DMD)","volume":"23","author":"Hsu","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jacbts.2021.11.004_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00264-009-0764-7","article-title":"Surgical management of severe scoliosis with high-risk pulmonary dysfunction in Duchenne muscular dystrophy","volume":"34","author":"Takaso","year":"2010","journal-title":"Int Orthop"},{"key":"10.1016\/j.jacbts.2021.11.004_bib23","first-page":"659","article-title":"The effect of Luque-Galveston fusion on curve, respiratory function and quality of life in Duchenne muscular dystrophy","volume":"77","author":"Van Opstal","year":"2011","journal-title":"Acta Orthop Belg"},{"key":"10.1016\/j.jacbts.2021.11.004_bib24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X\u00a0chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.11.004_bib25","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","article-title":"Genetic background affects properties of satellite cells and mdx phenotypes","volume":"176","author":"Fukada","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacbts.2021.11.004_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.omtm.2017.06.006","article-title":"A\u00a0five-repeat micro-dystrophin gene ameliorated dystrophic phenotype in the severe DBA\/2J-mdx model of Duchenne muscular dystrophy","volume":"6","author":"Hakim","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jacbts.2021.11.004_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","article-title":"Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice","volume":"143","author":"Sacco","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jacbts.2021.11.004_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ncb2790","article-title":"Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy","volume":"15","author":"Mourkioti","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fgene.2020.00131","article-title":"The genetic landscape of dystrophin mutations in Italy: a nationwide study","volume":"11","author":"Neri","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.jacbts.2021.11.004_bib31","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/humu.21114","article-title":"Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort","volume":"30","author":"Flanigan","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacbts.2021.11.004_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjcard.2014.04.038","article-title":"Left ventricular dysfunction in duchenne muscular dystrophy and genotype","volume":"114","author":"Ashwath","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jacbts.2021.11.004_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00246-004-0689-2","article-title":"Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies","volume":"26","author":"Kirchmann","year":"2005","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12931-019-1200-1","article-title":"Influence of \u03b2(2) adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy","volume":"20","author":"Kelley","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jacbts.2021.11.004_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.0b013e318207afeb","article-title":"SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy","volume":"76","author":"Pegoraro","year":"2011","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.jacbts.2021.11.004_bib37","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.3390\/ijms21207466","article-title":"The BDNF rs6265 polymorphism is a modifier of cardiomyocyte contractility and dilated cardiomyopathy","volume":"21","author":"Raucci","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2021.11.004_bib38","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/21678707.2015.1088780","article-title":"Gene therapy for Duchenne muscular dystrophy","volume":"3","author":"Ramos","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.jacbts.2021.11.004_bib39","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/mt.2012.283","article-title":"Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy","volume":"21","author":"Shin","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2021.11.004_bib40","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/hmg\/ddv310","article-title":"Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus","volume":"24","author":"Yue","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"418","key":"10.1016\/j.jacbts.2021.11.004_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacbts.2021.11.004_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/nat.2011.0306","article-title":"Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity","volume":"21","author":"Malerba","year":"2011","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.jacbts.2021.11.004_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198897","article-title":"Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-\/-mdx mouse models of Duchenne muscular dystrophy","volume":"13","author":"Blain","year":"2018","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jacbts.2021.11.004_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020599118","article-title":"Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms","volume":"118","author":"Ng","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.11.004_bib45","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1002\/anie.201506030","article-title":"Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing","volume":"54","author":"Sun","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.jacbts.2021.11.004_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature25164","article-title":"Treatment of autosomal dominant hearing loss by in\u00a0vivo delivery of genome editing agents","volume":"553","author":"Gao","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2021.11.004_bib47","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.1520244113","article-title":"Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.11.004_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in\u00a0vitro and in\u00a0vivo","volume":"33","author":"Zuris","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib49","doi-asserted-by":"crossref","first-page":"1700175","DOI":"10.1002\/advs.201700175","article-title":"Genome editing for cancer therapy: delivery of Cas9 protein\/sgRNA plasmid via a gold nanocluster\/lipid core-shell nanocarrier","volume":"4","author":"Wang","year":"2017","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jacbts.2021.11.004_bib50","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1021\/acsnano.6b07600","article-title":"Direct cytosolic delivery of CRISPR\/Cas9-ribonucleoprotein for efficient gene editing","volume":"11","author":"Mout","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jacbts.2021.11.004_bib51","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","article-title":"Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in\u00a0vivo induces homology-directed DNA repair","volume":"1","author":"Lee","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jacbts.2021.11.004_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/jacs.7b11754","article-title":"Endosomal escape and delivery of CRISPR\/Cas9 genome editing machinery enabled by nanoscale zeolitic imidazolate framework","volume":"140","author":"Alsaiari","year":"2018","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.jacbts.2021.11.004_bib53","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2021.11.004_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2021.11.004_bib55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jacbts.2021.11.004_bib56","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/mt.2014.62","article-title":"Inflammation converts human mesoangioblasts into targets of alloreactive immune responses: implications for allogeneic cell therapy of DMD","volume":"22","author":"Noviello","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2021.11.004_bib57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","article-title":"Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial","volume":"2","author":"Silva","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib59","doi-asserted-by":"crossref","first-page":"920517","DOI":"10.1155\/2012\/920517","article-title":"Pentraxin 3 (PTX 3): an endogenous modulator of the inflammatory response","volume":"2012","author":"Kunes","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jacbts.2021.11.004_bib60","doi-asserted-by":"crossref","first-page":"33362","DOI":"10.1038\/srep33362","article-title":"Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy","volume":"6","author":"Frohlich","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2021.11.004_bib61","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fphys.2020.00403","article-title":"PTX3 predicts myocardial damage and fibrosis in Duchenne muscular dystrophy","volume":"11","author":"Farini","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102279","article-title":"A\u00a0novel anti-inflammatory role of omega-3 PUFAs in prevention and treatment of atherosclerosis and vascular cognitive impairment and dementia","volume":"11","author":"Simonetto","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.jacbts.2021.11.004_bib63","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/ar.24563","article-title":"Fish oil attenuated dystrophic muscle markers of inflammation via FFA1 and FFA4 in the mdx mouse model of DMD","volume":"304","author":"Maciel Junior","year":"2020","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.jacbts.2021.11.004_bib64","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14018","article-title":"Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy","volume":"7","author":"Kim","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1016\/j.jacbts.2021.11.004_bib65","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/ar.24341","article-title":"Cardiac and skeletal muscle changes associated with rosuvastatin therapy in dystrophic mdx mice","volume":"303","author":"Finkler","year":"2020","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.jacbts.2021.11.004_bib66","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacbts.2021.11.004_bib67","first-page":"120","article-title":"Adiponectin: a versatile player of innate immunity","volume":"8","author":"Luo","year":"2016","journal-title":"J\u00a0Mol Cell Biol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","article-title":"Adiponectin as an anti-inflammatory factor","volume":"380","author":"Ouchi","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacbts.2021.11.004_bib69","doi-asserted-by":"crossref","first-page":"678627","DOI":"10.1155\/2013\/678627","article-title":"The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders","volume":"2013","author":"Benetti","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jacbts.2021.11.004_bib70","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2353\/ajpath.2010.090058","article-title":"Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle","volume":"176","author":"Rawat","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12915-018-0501-z","article-title":"Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy","volume":"16","author":"Boursereau","year":"2018","journal-title":"BMC Biol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2011.04.019","article-title":"The effects of ghrelin on inflammation and the immune system","volume":"340","author":"Baatar","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib73","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.peptides.2009.09.004","article-title":"Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect","volume":"30","author":"Huang","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.jacbts.2021.11.004_bib74","first-page":"2107","article-title":"Ghrelin attenuates renal fibrosis and inflammation of obstructive nephropathy","volume":"193","author":"Sun","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib75","doi-asserted-by":"crossref","first-page":"116654","DOI":"10.1016\/j.lfs.2019.116654","article-title":"Ghrelin improves muscle function in dystrophin-deficient mdx mice by inhibiting NLRP3 inflammasome activation","volume":"232","author":"Chang","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.jacbts.2021.11.004_bib76","doi-asserted-by":"crossref","first-page":"654425","DOI":"10.3389\/fphar.2021.654425","article-title":"P2X7 receptor-mediated inflammation in cardiovascular disease","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib77","doi-asserted-by":"crossref","first-page":"627773","DOI":"10.3389\/fphar.2021.627773","article-title":"P2Y1 receptor agonist attenuates cardiac fibroblasts activation triggered by TGF-\u03b21","volume":"12","author":"Tian","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib78","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1038\/s41598-020-70956-5","article-title":"Modulation of P2Y(6)R expression exacerbates pressure overload-induced cardiac remodeling in mice","volume":"10","author":"Shimoda","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2021.11.004_bib79","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1038\/emboj.2008.237","article-title":"P2Y6 receptor-Galpha12\/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis","volume":"27","author":"Nishida","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.jacbts.2021.11.004_bib80","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bbadis.2019.01.002","article-title":"Dystrophic mdx mouse myoblasts exhibit elevated ATP\/UTP-evoked metabotropic purinergic responses and alterations in calcium signalling","volume":"1865","author":"R\u00f3g","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jacbts.2021.11.004_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40478-018-0530-4","article-title":"Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism","volume":"6","author":"Al-Khalidi","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jacbts.2021.11.004_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-006-9048-5","article-title":"Purinergic signalling in the immune system. A brief update","volume":"3","author":"Di Virgilio","year":"2007","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.jacbts.2021.11.004_bib83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jacbts.2021.11.004_bib84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jprot.2016.03.011","article-title":"Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy","volume":"145","author":"Murphy","year":"2016","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.jacbts.2021.11.004_bib85","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1113\/JP277306","article-title":"Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy","volume":"598","author":"Hughes","year":"2020","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib86","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1440-1681.2006.04394.x","article-title":"Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species","volume":"33","author":"Whitehead","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib87","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jcsm.12405","article-title":"Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2 O2 emission during impaired oxidative phosphorylation","volume":"10","author":"Hughes","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jacbts.2021.11.004_bib88","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1113\/jphysiol.2012.240390","article-title":"Peroxisome proliferator-activated receptor gamma coactivator1- gene alpha transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post-necrotic mdx mouse skeletal muscle","volume":"590","author":"Godin","year":"2012","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib89","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.mehy.2015.08.015","article-title":"Revisiting the dystrophin-ATP connection: how half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology","volume":"85","author":"Timpani","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jacbts.2021.11.004_bib90","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1074\/jbc.270.2.672","article-title":"The sodium-calcium antiport of heart mitochondria is not electroneutral","volume":"270","author":"Jung","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.11.004_bib91","doi-asserted-by":"crossref","first-page":"H846","DOI":"10.1152\/ajpheart.00688.2006","article-title":"Intracellular calcium handling in ventricular myocytes from mdx mice","volume":"292","author":"Williams","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib92","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nature03844","article-title":"Dystrophic heart failure blocked by membrane sealant poloxamer","volume":"436","author":"Yasuda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2021.11.004_bib93","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/cvr\/cvx201","article-title":"Deficit in PINK1\/PARKIN-mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy","volume":"114","author":"Kang","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2021.11.004_bib94","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.11.004_bib95","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00018-007-6484-5","article-title":"Molecular basis for chemoprevention by sulforaphane: a comprehensive review","volume":"64","author":"Juge","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jacbts.2021.11.004_bib96","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1152\/japplphysiol.00721.2015","article-title":"Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-beta\/Smad signaling","volume":"120","author":"Sun","year":"2016","journal-title":"J\u00a0Appl Physiol (1985)"},{"issue":"7","key":"10.1016\/j.jacbts.2021.11.004_bib97","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00210-021-02072-8","article-title":"Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review","volume":"394","author":"Yarmohammadi","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.jacbts.2021.11.004_bib98","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3892\/mmr.2021.12157","article-title":"Hydrogen sulfide attenuates renal I\/R-induced activation of the inflammatory response and apoptosis via regulating Nrf2-mediated NLRP3 signaling pathway inhibition","volume":"24","author":"Su","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jacbts.2021.11.004_bib99","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nmd.2008.03.008","article-title":"Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart","volume":"18","author":"Spurney","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jacbts.2021.11.004_bib100","doi-asserted-by":"crossref","first-page":"13165","DOI":"10.1073\/pnas.1004509107","article-title":"Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy","volume":"107","author":"Sarma","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.11.004_bib101","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/cvt163","article-title":"Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy","volume":"99","author":"Iwata","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2021.11.004_bib102","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2169\/internalmedicine.8651-16","article-title":"A\u00a0pilot study of tranilast for cardiomyopathy of muscular dystrophy","volume":"57","author":"Matsumura","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.jacbts.2021.11.004_bib103","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.RES.0000178788.76568.8a","article-title":"Distinct pathways regulate expression of cardiac electrical and mechanical junction proteins in response to stretch","volume":"97","author":"Yamada","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2021.11.004_bib104","doi-asserted-by":"crossref","first-page":"13490","DOI":"10.1038\/srep13490","article-title":"Selective connexin43 inhibition prevents isoproterenol-induced arrhythmias and lethality in muscular dystrophy mice","volume":"5","author":"Gonzalez","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2021.11.004_bib105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nmd.2018.01.012","article-title":"Normalization of connexin 43 protein levels prevents cellular and functional signs of dystrophic cardiomyopathy in mice","volume":"28","author":"Gonzalez","year":"2018","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.jacbts.2021.11.004_bib106","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI128190","article-title":"Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy","volume":"130","author":"Himelman","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"15","key":"10.1016\/j.jacbts.2021.11.004_bib107","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.3390\/ijms21155415","article-title":"Apocynin treatment prevents cardiac connexin 43 hemichannels hyperactivity by reducing nitroso-redox stress in mdx mice","volume":"21","author":"Vielma","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2021.11.004_bib108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1074\/jbc.M110.163477","article-title":"Pannexin 1 constitutes the large conductance cation channel of cardiac myocytes","volume":"286","author":"Kienitz","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.11.004_bib109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1085\/jgp.201711888","article-title":"Revisiting multimodal activation and channel properties of Pannexin 1","volume":"150","author":"Chiu","year":"2018","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075340","article-title":"Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy","volume":"8","author":"Valladares","year":"2013","journal-title":"PloS One"},{"issue":"3 suppl 1","key":"10.1016\/j.jacbts.2021.11.004_bib111","doi-asserted-by":"crossref","first-page":"486A","DOI":"10.1016\/j.bpj.2017.11.2671","article-title":"Increased pannexin 1 expression and activity in ventricle of mdx dystrophic hearts","volume":"114","author":"Raucci","year":"2018","journal-title":"Biophys J"},{"key":"10.1016\/j.jacbts.2021.11.004_bib112","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCRESAHA.117.312380","article-title":"Pannexin 1 channels as an unexpected new target of the anti-hypertensive drug spironolactone","volume":"122","author":"Good","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2021.11.004_bib113","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1083\/jcb.201502100","article-title":"BDNF modulates heart contraction force and long-term homeostasis through truncated TrkB.T1 receptor activation","volume":"210","author":"Fulgenzi","year":"2015","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib114","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/pr.2015.257","article-title":"Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac\/skeletal muscle function in Duchenne muscular dystrophy","volume":"79","author":"Galindo","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacbts.2021.11.004_bib115","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1590\/0001-3765201520140508","article-title":"Neurotrophins, cytokines, oxidative parameters and funcionality in progressive muscular dystrophies","volume":"87","author":"Comim","year":"2015","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.jacbts.2021.11.004_bib116","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12916-020-01805-5","article-title":"The nSMase2\/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice","volume":"18","author":"Matsuzaka","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.jacbts.2021.11.004_bib117","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice","volume":"124","author":"Rafael-Fortney","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.11.004_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088360","article-title":"Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy","volume":"9","author":"Janssen","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jacbts.2021.11.004_bib119","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib120","article-title":"Stabilization of early Duchenne cardiomyopathy with aldosterone inhibition: results of the multicenter AIDMD trial","volume":"8","author":"Raman","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.11.004_bib121","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1161\/CIR.0000000000000526","article-title":"Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association","volume":"136","author":"Feingold","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.11.004_bib122","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10741-018-9757-1","article-title":"Practical guidance on the use of sacubitril\/valsartan for heart failure","volume":"24","author":"Sauer","year":"2019","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2021.11.004_bib123","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril\u00a0in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.11.004_bib124","first-page":"9112","article-title":"Duchenne muscular dystrophy: preliminary experience with sacubitril-valsartan in patients with asymptomatic left ventricular dysfunction","volume":"24","author":"Lamendola","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jacbts.2021.11.004_bib125","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jacc.2019.12.066","article-title":"Stem cell-derived cardiomyocytes and beta-adrenergic receptor blockade in Duchenne muscular dystrophy cardiomyopathy","volume":"75","author":"Kamdar","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib126","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2169\/internalmedicine.49.3259","article-title":"Carvedilol can prevent cardiac events in Duchenne muscular dystrophy","volume":"49","author":"Matsumura","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.jacbts.2021.11.004_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057260","article-title":"Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy","volume":"8","author":"Blain","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2021.11.004_bib128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2019.01.052","article-title":"Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy","volume":"280","author":"Adorisio","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2021.11.004_bib129","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijcard.2016.08.135","article-title":"Effect of ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: a chance for slowing progression of heart failure?","volume":"223","author":"De Benedittis","year":"2016","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.jacbts.2021.11.004_bib130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10517-009-0564-5","article-title":"A new genetic variant of mdx mice: study of the phenotype","volume":"147","author":"Krivov","year":"2009","journal-title":"Bull Exp Biol Med"},{"issue":"4","key":"10.1016\/j.jacbts.2021.11.004_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002042","article-title":"DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies","volume":"7","author":"Schmidt","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jacbts.2021.11.004_bib132","article-title":"The FVB background does not dramatically alter the dystrophic phenotype of Mdx mice","volume":"7","author":"Wasala","year":"2015","journal-title":"PLoS Curr"},{"issue":"4","key":"10.1016\/j.jacbts.2021.11.004_bib133","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1073\/pnas.86.4.1292","article-title":"Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice","volume":"86","author":"Chapman","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jacbts.2021.11.004_bib134","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","article-title":"Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that\u00a0observed in Duchenne muscular dystrophy","volume":"238","author":"Araki","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.jacbts.2021.11.004_bib135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1097-0177(199806)212:2<229::AID-AJA7>3.0.CO;2-J","article-title":"Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene","volume":"212","author":"Wertz","year":"1998","journal-title":"Dev Dyn"},{"issue":"2","key":"10.1016\/j.jacbts.2021.11.004_bib136","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbrc.2004.12.191","article-title":"A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system","volume":"328","author":"Kudoh","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.jacbts.2021.11.004_bib137","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/hmg\/ddl018","article-title":"Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular\u00a0dystrophy","volume":"15","author":"Guo","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.jacbts.2021.11.004_bib138","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jacbts.2021.11.004_bib139","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","article-title":"Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy","volume":"90","author":"Grady","year":"1997","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.jacbts.2021.11.004_bib140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1101\/gad.10.10.1173","article-title":"MyoD is required for myogenic stem cell function in adult skeletal muscle","volume":"10","author":"Megeney","year":"1996","journal-title":"Genes Dev"},{"issue":"42","key":"10.1016\/j.jacbts.2021.11.004_bib141","doi-asserted-by":"crossref","first-page":"42ra54","DOI":"10.1126\/scitranslmed.3000692","article-title":"A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy","volume":"2","author":"Chandrasekharan","year":"2010","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.jacbts.2021.11.004_bib142","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/12034","article-title":"Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies","volume":"1","author":"Grady","year":"1999","journal-title":"Nat Cell Biol"},{"issue":"7","key":"10.1016\/j.jacbts.2021.11.004_bib143","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/ddp015","article-title":"Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice","volume":"18","author":"Li","year":"2009","journal-title":"Hum Mol Genet"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X2100365X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X2100365X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:24:49Z","timestamp":1762820689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X2100365X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":143,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2452302X2100365X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.11.004","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Disease in Duchenne\u00a0Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}